,i #aaith ,,congress #ast ,session ,h4 ,r4 #bdhd ,,in ,,the ,,house ,,of ,,representatives ,march #ca1 #bjbe,mrs4 ,harshbarger 7for herself1 ,ms4 ,wasserman ,schultz1 ,mrs4 ,miller of ,west ,virginia1 ,mr4 ,soto1 ,mr4 ,crenshaw1 and ,mr4 ,davis of ,north ,carolina7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to establish an exception to the physician self-referral prohibition for certain outpatient prescription drugs furnished by a physician practice under the ,medicare program4 #a4 ,short title ,this ,act may be cited as the ,seniors' ,access to ,critical ,medications ,act of #bjbe4 #b4 ,establishing an exception to the physician self-referral prohibition for certain outpatient prescription drugs furnished by a physician practice under the ,medicare program 7a7 ,in general ,section #ahgg7;b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acienn7b77 is amended by adding at the end the following new paragraph3 7#f7 ,certain outpatient prescription drugs 7,a7 ,in general ,in the case of designated health services described in subsection 7h77#f77;,j7 that are covered part ,d drugs 7as defined in section #ahfj;,d-#b7;e77 and furnished to an individual during the period beginning on ,january #a1 #bjbf1 and ending on ,december #ca1 #bjcj1 if-- 7i7 such drugs are prescribed by the referring physician 7or by another physician or practitioner 7as described in section #ahdb7;b77#ah77;,c77 within the same group practice as such physician72 7ii7 such individual has an ongoing relationship 7as defined by the ,secretary7 with such physician or practitioner who prescribed such drugs 7or with another physician or practitioner within the same group practice as such physician or practitioner72 7iii7 within the #a-year period prior to the dispensing of such drugs1 such individual had at least #a face-to-face1 in-person encounter with such referring physician 7or with another physician or practitioner within the same group practice as such physician1 as determined by tax identification number7 during which items or services that are not designated health services and for which payment was made under this title were furnished to such individual2 7iv7 such drugs are dispensed by the referring physician1 a physician who is a member of the same group practice as the referring physician1 or an individual who is directly supervised by such a physician1 from a building described in paragraph 7#b77;,a77ii71 including through-- 7,i7 in-person pickup by the individual or a caregiver or family member of such individual2 or 7,,ii7 a mail1 delivery1 or courier service2 and 7v7 such drugs are billed for by the physician dispensing or supervising the dispensing of such drugs1 by a group practice of which such physician is a member under a billing number assigned to such group practice1 or by an entity that is wholly owned by such physician or such group practice4 7,b7 ,rule of ,construction ,nothing in subparagraph 7,a7 shall be construed as modifying any program requirements under part ,d4 4 7b7 ,,gao study and report 7#a7 ,study ,the ,comptroller ,general of the ,united ,states 7in this section referred to as the ,comptroller ,general7 shall conduct a study examining-- 7,a7 pharmacies or pharmacy networks participating under part ,d of title ,,xviii of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aja et seq47 that1 after the date of the enactment of this section1 dispense significantly more 7as determined by the ,comptroller ,general7 covered part ,d drugs 7as defined in section #ahfj;,d-#b of such ,act 7#db ,u4,s4,c4 #acie;e-#ajb77 compared to the amount of such drugs dispensed prior to such date2 7,b7 common characteristics of the pharmacies and pharmacy networks identified under subparagraph 7,a71 including1 to the extent identifiable1 the extent to which such pharmacies and pharmacy networks are owned by a physician or group practice 7as defined in section #ahgg7;h7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acienn7h77 or otherwise integrated into a physician's practice or group practice2 and 7,c7 common characteristics of arrangements entered into by physicians or group practices for purposes of dispensing drugs within physicians' offices or otherwise integrating pharmacies or the dispensing of drugs into a physician's practice or group practice1 including1 to the extent feasible and identifiable1 an analysis of-- 7i7 specific physician specialties or subspecialties for which such arrangements are especially common or have shown substantial growth2 7ii7 the extent to which physicians and group practices participating in such arrangements have such arrangements or integration with other physicians or group practices or other drug supply chain participants 7including pharmacy benefit managers1 insurers1 wholesalers1 distributors1 or management services organizations72 7iii7 common contracting features of such arrangements relating to the utilization of covered part ,d drugs or services provided in connection with such drugs1 including contract terms related to administrative or dispensing fees for such drugs and the types of payments provided in connection with such services2 7iv7 common measures1 including notices or disclosures1 taken by physicians and group practices participating in such arrangements in order to mitigate or otherwise address potential conflicts of interest posed by such arrangements2 and 7v7 any components or features of such arrangements that may influence prescribing decisions or patterns among physicians and group practices participating in such arrangements4 7#b7 ,report ,not later than #c years after the date of the enactment of this section1 the ,comptroller ,general shall submit to ,congress a report on the findings of the study required under paragraph 7#a71 which shall not include identifying or proprietary information with respect to the pharmacies or pharmacy networks examined4 #c4 ,medicare improvement fund ,section #ahih7;b77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;iii7b77#a77 is amended by striking #a1hjd1jjj1jjj and inserting #a1ghf1jjj1jjj4